A piece of news
The company has moved its sales and corporate headquarters to Silicon Valley and has opened a branch in Mexico
Medtep, a start-up that has developed a technological solution for treatment and wellbeing through preventing and monitoring diseases, has closed its first round of funding and taken the leap to Silicon Valley and Mexico.
The investment, a total of two million dollars, was led by Mexican fund Stella Maris Partners. American and Spanish investors also participated, including Iñigo Juantegui (co-founder of neveraroja.com), Pablo Juantegui (CEO of Telepizza), Carlos Gallardo (through CG Health Ventures) and renowned pediatrician Carlos González. “Many of the investors have some sort of ties to the sector because the aim was for them to contribute not only funding but also value to the company,” explains Pablo Pantaleoni, co-founder and CEO of Medtep.
The company will use this capital to consolidate its internationalization strategy. Thanks to this investment, Medtep has moved its sales and corporate headquarters to Silicon Valley (San Francisco, USA) and opened offices in Mexico. This move is key, according to Pantaleoni, “to achieve the milestone of establishing a presence in the United States and gaining presence in Latin America.” The Silicon Valley headquarters will be headed up by Pantaleoni, while a team of more than 25 employees will continue working on product development and innovation in Barcelona, where the company was created.
Medtep was set up in 2011 by Pablo Pantaleoni (degree in Business Administration and Economics) and Jacob Suñol (computer engineer). It is a platform to improve communication between doctors, who enter medical information on the uClinics site, and patients, who can see their medical history and the treatments to follow on uPatient. It is a personalized medicine solution in which each patient follows their own treatment regimen through plans established by healthcare professionals according to their condition and lifestyle.